Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 2Unknown 1

Sponsor Class

OTHER_GOV 1OTHER 1INDUSTRY 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Genitourinary 3Endocrine 1

Conditions

Prostatic Neoplasms 6268Carcinoma, Renal Cell 1913Urinary Bladder Neoplasms 1670Kidney Neoplasms 930Breast Neoplasms 793Neoplasms 788Carcinoma, Transitional Cell 594Carcinoma, Non-Small-Cell Lung 524Neoplasm Metastasis 510Melanoma 485Ovarian Neoplasms 468Colorectal Neoplasms 454Lung Neoplasms 435Pancreatic Neoplasms 325Testicular Neoplasms 290Stomach Neoplasms 274Sarcoma 267Uterine Cervical Neoplasms 264Non-Muscle Invasive Bladder Neoplasms 263Head and Neck Neoplasms 241Colonic Neoplasms 217Esophageal Neoplasms 203Squamous Cell Carcinoma of Head and Neck 202Carcinoma, Hepatocellular 197Wilms Tumor 196Endometrial Neoplasms 189Recurrence 162Neuroblastoma 148Urologic Neoplasms 147Small Cell Lung Carcinoma 146

Interventions

lornoxicam 1Ofloxacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Cystitis × Genitourinary × Clear all
NCT05337189 2025-02-13

A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China

Creative Biosciences (Guangzhou) Co., Ltd.

Recruiting
482 enrolled
Genitourinary

Urinary Bladder Calculi, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Cystitis

NCT06719232 2024-12-12

NOCATIN

Jahn Ferenc South Pest Teaching Hospital

Recruiting
300 enrolled
Genitourinary

Cystitis, Hemorrhagic, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Cystitis, Urinary Tract Infections, Cystitis, Interstitial

NCT03038321 2017-05-23

Solifenacin, Levofloxacin or Lornoxicam, Which Is Ideal for Management of Intravesical Instillation BCG Side Effects?

Mansoura University

Phase 4 Unknown
150 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Cystitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡